4.8 Article

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils

期刊

SCIENCE
卷 358, 期 6367, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aal5081

关键词

-

资金

  1. NIH [P30-AR066261, R01-A1084880, R01-0A206890, P50-CA86355, U54-CA126515, CA148180, L54-CA163109, R33-CA212697]
  2. Samana Coy MGH (Massachusetts General Hospital) Research Scholar Fund
  3. Robert Wenner Award from the Swiss Cancer League
  4. Howard Hughes Medical Institute
  5. Edward J. Mallinckrodt Jr. Fellowship
  6. Boehringer Ingelheirn Fonds PhD fellowships
  7. Deutsche Forschirgsgemeinschaft [PF809/1-1]
  8. MGH ECOR (Executive Committee on Research) Tosteson Postdoctoral Fellowship
  9. MIT (Massachdsetts Institute of Technology) Ludwig Center for Molecular Oncology Research
  10. National Institute of General Medical Sciences [T32-GM007753]

向作者/读者索取更多资源

Bone marrow-derived myeloid cells can accumulate within tumors and foster cancer outgrowth. Local immune-neoplastic interactions have been intensively investigated, but the contribution of the systemic host environment to tumor growth remains poorly understood. Here, we show in mice and cancer patients (n = 70) that lung adenocarcinomas increase bone stromal activity in the absence of bone metastasis. Animal studies reveal that the cancer-induced bone phenotype involves bone-resident osteocalcin-expressing (Ocn(+)) osteoblastic cells. These cells promote cancer by remotely supplying a distinct subset of tumor-infiltrating SiglecF(high) neutrophils, which exhibit cancer-promoting properties. Experimentally reducing Ocn(+) cell numbers suppresses the neutrophil response and lung tumor outgrowth. These observations posit osteoblasts as remote regulators of lung cancer and identify SiglecF(high) neutrophils as myeloid cell effectors of the osteoblast-driven protumoral response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据